WallStSmart

Alphabet Inc Class C (GOOG)vsTNL Mediagene Ordinary Shares (TNMG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Alphabet Inc Class C generates 897493% more annual revenue ($445.87B vs $49.67M). GOOG leads profitability with a 54.8% profit margin vs -167.9%. GOOG earns a higher WallStSmart Score of 75/100 (B).

GOOG

Strong Buy

75

out of 100

Grade: B

Growth: 8.7Profit: 9.5Value: 7.3Quality: 8.5
Piotroski: 4/9Altman Z: 3.92

TNMG

Avoid

32

out of 100

Grade: F

Growth: 6.7Profit: 2.0Value: 5.0Quality: 3.0
Piotroski: 4/9Altman Z: -7.25
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

GOOGUndervalued (+29.4%)

Margin of Safety

+29.4%

Fair Value

$474.89

Current Price

$335.45

$139.44 discount

UndervaluedFair: $474.89Overvalued

Intrinsic value data unavailable for TNMG.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GOOG6 strengths · Avg: 10.0/10
Market CapQuality
$4.10T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
38.1%10/10

Every $100 of equity generates 38 in profit

Profit MarginProfitability
54.8%10/10

Keeps 55 of every $100 in revenue as profit

Operating MarginProfitability
34.0%10/10

Strong operational efficiency at 34.0%

EPS GrowthGrowth
294.0%10/10

Earnings expanding 294.0% YoY

Altman Z-ScoreHealth
3.9210/10

Safe zone — low bankruptcy risk

TNMG1 strengths · Avg: 10.0/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Areas to Watch

GOOG1 concerns · Avg: 2.0/10
Free Cash FlowQuality
$-5.86B2/10

Negative free cash flow — burning cash

TNMG4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$2.66M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-164.6%2/10

ROE of -164.6% — below average capital efficiency

Free Cash FlowQuality
$-3.15M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : GOOG

The strongest argument for GOOG centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 54.8% and operating margin at 34.0%. Revenue growth of 24.2% demonstrates continued momentum.

Bull Case : TNMG

The strongest argument for TNMG centers on Price/Book.

Bear Case : GOOG

The primary concerns for GOOG are Free Cash Flow.

Bear Case : TNMG

The primary concerns for TNMG are EPS Growth, Market Cap, Return on Equity. Debt-to-equity of 23.52 is elevated, increasing financial risk.

Key Dynamics to Monitor

GOOG profiles as a growth stock while TNMG is a turnaround play — different risk/reward profiles.

GOOG carries more volatility with a beta of 1.23 — expect wider price swings.

GOOG is growing revenue faster at 24.2% — sustainability is the question.

TNMG generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

GOOG scores higher overall (75/100 vs 32/100), backed by strong 54.8% margins and 24.2% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alphabet Inc Class C

COMMUNICATION SERVICES · INTERNET CONTENT & INFORMATION · USA

Alphabet Inc. is an American multinational conglomerate headquartered in Mountain View, California. It was created through a restructuring of Google on October 2, 2015, and became the parent company of Google and several former Google subsidiaries. The two co-founders of Google remained as controlling shareholders, board members, and employees at Alphabet. Alphabet is the world's fourth-largest technology company by revenue and one of the world's most valuable companies.

Visit Website →

TNL Mediagene Ordinary Shares

COMMUNICATION SERVICES · PUBLISHING · USA

TNL Mediagene Ordinary Shares is an innovative biopharmaceutical firm focused on developing and commercializing cutting-edge therapies for oncology and autoimmune disorders. The company boasts a strong pipeline driven by advanced technologies and strategic collaborations, positioning it for significant growth in the evolving healthcare market. TNL Mediagene's commitment to scientific excellence and patient-centered solutions reinforces its aim to enhance patient outcomes while addressing critical health challenges, thereby establishing itself as a notable entity within the biopharmaceutical landscape.

Visit Website →

Want to dig deeper into these stocks?